Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 3325 of 3546 entries
View as:

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

Phase: N/A Priority: Normal
NCT ID: NCT01098539 Org: User:
Start: 05/31/10 End: 11/30/12 Due: 11/30/13

A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00273039 Org: User:
Start: 08/31/05 End: 09/30/06 Due: 09/30/07

Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01323621 Org: User:
Start: 03/18/11 End: 01/24/12 Due: 01/24/13

Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Non-Dialysis (ASCEND-ND)

Phase: N/A Priority: Normal
NCT ID: NCT02876835 Org: User:
Start: 09/27/16 End: 04/19/21 Due: 04/19/22

Study Of Adults And Adolescents With Vasomotor Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT00117325 Org: User:
Start: 07/11/05 End: 02/09/06 Due: 02/09/07

Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea

Phase: N/A Priority: Normal
NCT ID: NCT01568060 Org: User:
Start: 05/21/12 End: 12/15/15 Due: 12/15/16

Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UK

Phase: N/A Priority: Normal
NCT ID: NCT01715792 Org: User:
Start: 10/31/12 End: 08/31/13 Due: 08/31/14

A Clinical Study to Assess Force Required to Dislodge Upper Denture With and Without Use of a Novel Denture Adhesive

Phase: N/A Priority: Normal
NCT ID: NCT04473521 Org: User:
Start: 10/04/20 End: 01/10/21 Due: 01/10/22

Study to Investigate Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of GSK2646264

Phase: N/A Priority: Normal
NCT ID: NCT02424799 Org: User:
Start: 11/17/14 End: 11/10/17 Due: 11/10/18

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

Phase: N/A Priority: Normal
NCT ID: NCT05243680 Org: User:
Start: 03/01/22 End: 05/19/25 Due: 05/19/26

Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06079190 Org: User:
Start: 10/20/23 End: 11/23/26 Due: 11/23/27

BE STUDY OF METFORMIN GSK 1000mg

Phase: N/A Priority: Normal
NCT ID: NCT01710553 Org: User:
Start: 07/31/12 End: 07/31/12 Due: 07/31/13

A Study To Investigate The Safety, Tolerability And Blood Levels Of GSK598809

Phase: N/A Priority: Normal
NCT ID: NCT00437840 Org: User:
Start: 03/20/07 End: 06/20/07 Due: 06/20/08

Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry

Phase: N/A Priority: Normal
NCT ID: NCT01729455 Org: User:
Start: 02/21/13 End: 02/28/25 Due: 02/28/26

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01389479 Org: User:
Start: 01/31/05 End: 05/31/05 Due: 05/31/06

A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain

Phase: N/A Priority: Normal
NCT ID: NCT05838742 Org: User:
Start: 09/13/23 End: 12/03/24 Due: 12/03/25

Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT01037127 Org: User:
Start: 11/30/09 End: 01/31/13 Due: 01/31/14

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT00232596 Org: User:
Start: 09/30/05 End: 01/31/08 Due: 01/31/09

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus (RSV) Given to Adults 18 to 49 Years of Age at Increased Risk for Respiratory Syncytial Virus Disease, Compared to Older Adults 60 Years of Age and Above

Phase: N/A Priority: Normal
NCT ID: NCT06389487 Org: User:
Start: 04/29/24 End: 03/18/25 Due: 03/18/26

Nicotine Mouth Film for Craving Relief.

Phase: N/A Priority: Normal
NCT ID: NCT01702532 Org: User:
Start: 09/30/12 End: 12/31/12 Due: 12/31/13

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Phase: N/A Priority: Normal
NCT ID: NCT01573767 Org: User:
Start: 04/30/12 End: 04/30/14 Due: 04/30/15

Intravenous Weekly Topotecan In Subjects With Recurrent Or Persistent Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00267488 Org: User:
Start: 10/31/05 End: 12/31/07 Due: 12/31/08

Investigation of Iron Uptake From Micronutrient Fortified Powder Versus From Tailored Control in Milk

Phase: N/A Priority: Normal
NCT ID: NCT02254460 Org: User:
Start: 02/06/13 End: 03/08/13 Due: 03/08/14

A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00459550 Org: User:
Start: 03/12/07 End: 05/30/11 Due: 05/30/12

Denosumab China Phase III Study

Phase: N/A Priority: Normal
NCT ID: NCT02014467 Org: User:
Start: 01/31/14 End: 08/31/15 Due: 08/31/16